What role does Zöliakie Test play in Blutzucker?

The celiac test (typically HLA-DQ2/DQ8 genotyping) is sometimes mentioned in the context of blood sugar because celiac disease is associated with type 1 diabetes. However, the test is not a direct blood sugar marker. It only indicates a genetic predisposition for celiac disease – an autoimmune condition that, if untreated, can cause malabsorption and indirectly affect blood sugar levels. In people with diabetes, undiagnosed celiac disease can complicate glycemic control. The MyBody-X test primarily analyzes other SNPs (e.g., lactose intolerance, fat metabolism) and does not offer a specific celiac test. Evidence for a direct role of celiac genetic testing in blood sugar regulation is weak. Clinically, antibody tests (tTG-IgA) and confirmed diagnosis are more relevant. The genetic test remains a risk indicator, not a diagnostic or therapeutic tool. Blood sugar management requires medical supervision, not standalone genetic analysis. Caution: a negative HLA result largely rules out celiac disease, but a positive result does not confirm it. Overall, the role of the celiac test in blood sugar is limited.